| Literature DB >> 34446809 |
Avina K Hunjan1,2, Christopher Hübel1,2,3, Yuhao Lin1, Thalia C Eley1,2, Gerome Breen4,5.
Abstract
Despite the observed associations between psychiatric disorders and nutrient intake, genetic studies are limited. We examined whether polygenic scores for psychiatric disorders are associated with nutrient intake in UK Biobank (N = 163,619) using linear mixed models. We found polygenic scores for attention-deficit/hyperactivity disorder, bipolar disorder, and schizophrenia showed the highest number of associations, while a polygenic score for autism spectrum disorder showed no association. The relatively weaker obsessive-compulsive disorder polygenic score showed the greatest effect sizes suggesting its association with diet traits may become more apparent with larger genome-wide analyses. A higher alcohol dependence polygenic score was associated with higher alcohol intake and individuals with higher persistent thinness polygenic scores reported their food to weigh less, both independent of socioeconomic status. Our findings suggest that polygenic propensity for a psychiatric disorder is associated with dietary behaviour. Note, nutrient intake was self-reported and findings must therefore be interpreted mindfully.Entities:
Mesh:
Year: 2021 PMID: 34446809 PMCID: PMC8390493 DOI: 10.1038/s42003-021-02469-4
Source DB: PubMed Journal: Commun Biol ISSN: 2399-3642
Descriptive statistics: age, sex, number of questionnaires completed, and nutrient intakes in 163,619 participants of the UK Biobank cohort.
| Age | 56.22 (7.89) | 40−72 |
|---|---|---|
| Males | 73,853 (45.1%) | |
| Females | 89,766 (54.9%) | |
| Total | 163,619 | |
| 1 | 65,296 (39.9%) | |
| 2 | 39,254 (24%) | |
| 3 | 33,539 (20.5 %) | |
| 4 | 21,732 (13.3%) | |
| 5 | 3,798 (2.3%) | |
| Alcohol (g) | 16.18 (22.73) | 0–149.63 |
| Protein (g) | 80.93 (29.96) | 0–294.54 |
| Carbohydrates (g) | 249.78 (87.66) | 0–834.88 |
| Fats (g) | 76.19 (31.97) | 0–270.35 |
| Fibre (g) | 16.32 (7.02) | 0–59.3 |
| Food weight (g) | 3162.84 (808.55) | 0–6361.5 |
| Folate (μg) | 298.17 (118.65) | 0–995.36 |
| Calcium (mg) | 961.25 (386.64) | 0–3934.24 |
| Carotene (μg) | 3044.85 (2860.47) | 0–24992.8 |
| Iron (mg) | 13.50 (4.67) | 0–39.93 |
| Vitamin B6 (μg) | 2.15 (0.78) | 0–6 |
| Vitamin B12 (μg) | 6.13 (4.73) | 0–49.33 |
| Vitamin C (μg) | 150.14 (110.63) | 0–997.45 |
| Vitamin D (μg) | 2.81 (3.22) | 0–24.76 |
| Vitamin E (μg) | 9.13 (4.77) | 0–47.31 |
Note. values are mean (standard deviation) and range (min−max) for age and nutrient intakes, and n (%) for sex and number of assessments completed.
Fig. 1Associations between polygenic scores for psychiatric disorders and nutrient intake.
Results are shown from linear mixed-effects model analyses. Y-axis shows the R2 estimates which have been scaled by the variance explained by the polygenic score predicting itself on the liability scale and have been multiplied by the direction of the coefficient estimate. Colours represent the different models: grey for Model 0 (i.e., baseline model) and yellow for Model 5 (i.e., full model) in configuration 1. Error bars represent standard errors and asterisks indicate statistically significant estimates. Bonferroni-corrected p-value thresholds: ∗ = p < 0.05/132, ∗∗ = p < 0.01/132, ∗∗∗ = p < 0.001/132. Data are represented for 163,619 participants of the UK Biobank cohort. The full results can be found in Supplementary Figs. 3 and 4.
Fig. 2Associations between polygenic scores for psychiatric, behavioural, and anthropometric traits and nutrient intake.
Results are shown from linear mixed-effects model analyses. Y-axis shows the R2 estimates which have been scaled by the variance explained by the polygenic score predicting itself on the liability scale and have been multiplied by the direction of the coefficient estimate. Colours represent the different models: grey for Model 0 (i.e., baseline model) and yellow for Model 5 (i.e., full model) in configuration 1. Error bars represent standard errors and asterisks indicate statistically significant estimates. Bonferroni-corrected p-value thresholds: ∗ = p < 0.05/132, ∗∗ = p < 0.01/132, ∗∗∗ = p < 0.001/132. Data are represented for 163,619 participants of the UK Biobank cohort. The full results can be found in Supplementary Figs. 3 and 4.
Exclusion of UK Biobank participants.
| Number of participants who completed the Diet by 24-h recall questionnaire at least once = 211,039 | |
|---|---|
| Exclusion criteria | Number of participants excluded |
| No genotype data | 43,036 |
| Pregnant (included those that were doubtful) | 132 |
| Missing data on variables that may potentially influence nutrient intake | 4,252 |
| - Age | |
| - Sex | |
| - SES | |
| - Educational attainment | |
| - Physical activity | |
| - Smoking | |
| - Alcohol consumption | |
| - Diagnoses and medication that affects dietary intake | |
| Participants remaining | 163,619 |
Table summarising genome-wide association study (GWAS) discovery sample size, SNP-based heritability on the observed scale.
| Trait | GWAS sample | Observed scale SNP-based heritability |
|---|---|---|
| Anorexia nervosa[ | 16,224 cases and 52,460 controls | 17.4% (1.2%) |
| Obsessive–compulsive disorder[ | 2,688 cases and 7,037 controls | 33.8% (4.8%) |
| Educational attainment[ | 766,345 individuals | 10.7% (0.2%) |
| Schizophrenia[ | 33,610 cases and 43,456 controls | 45.5% (1.6%) |
| Attention-deficit/hyperactivity disorder[ | 19,099 cases, 34,194 controls | 24% (1.5%) |
| Alcohol dependence[ | 11,569 cases and 34,999 controls | 5.4% (1%) |
| Major depressive disorder[ | 116,404 cases and 314,990 controls | 5.7% (0.2%) |
| Bipolar disorder[ | 20,352 cases and 31,358 controls | 21% (1.1%) |
| Autism spectrum disorder[ | 18,381 cases and 27,969 controls | 12% (1.0%) |
| Food addiction[ | 9,314 females | 10% (4%) |
| Persistent thinness[ | 1,471 cases and 6,460 controls | 16.7% (3.9%) |
| Height[ | 253,288 individuals | 31.2% (1.4%) |
| Body mass index[ | 322,154 individuals | 13% (0.5%) |
| Body fat percentage[ | 100,716 individuals | 10.4% (0%) |
| Systemic lupus erythematosus[ | 7,219 cases and 15,991 controls | 33.3% (9.7%) |
Table summarising the fixed effects included in the linear mixed-effects models. Configurations 1 and 2 represent the models presented in Supplementary Figs. 3/5 and 4/6, respectively.
| Configuration 1 - fixed effects grouped and differently assessed | ||
|---|---|---|
| 0 | Supplementary | Polygenic score under investigation, sex, age + principal components 1−6 |
| 1 | Main | Model 0 + special diet and typical diet yesterday |
| 2 | Main | Model 1 + socioeconomic status and educational attainment |
| 3 | Main | Model 1 + physical activity |
| 4 | Main | Model 1 + smoking, alcohol consumption and diagnoses and medication that affect dietary intake |
| 5 | Main | All fixed effects |
| Configuration 2 - fixed effects grouped and added in a stepwise manner | ||
| 0 | Supplementary | Polygenic score under investigation, sex, age + principal components 1−6 |
| 1 | Supplementary | Model 0 + special diet and typical diet yesterday |
| 2 | Supplementary | Model 1 + socioeconomic status and educational attainment |
| 3 | Supplementary | Model 2 + smoking, alcohol consumption and diagnoses and medication that affect dietary intake |
| 4 | Supplementary | Model 3 + physical activity |